SARS CoronavirusNCIt concept

https://iris.who.int/bitstream/handle/10665/376333/WHO-WHE-EPP-2024.3-fre.pdf
2024
Switzerland
public health guidelines
Montreal Cognitive Assessment Orientation Test
Biological Son
Biological or Textual Reference to Actual Test or Parameter
CDISC ADAS-Cog - Orientation Summary Score
orientation
biology
Clinical Trial Notification of Safety or Other Trial Information Documentation
Referral
Biological
Biological Challenge Agent
SARS Coronavirus
laboratory reporting, nos
Biology
biology
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
SARS-CoV-2
safety
containment of biohazards
Direction
Orientation
Referring
Safety Report
laboratories
COVID-19 Infection
Biological Agent
orientation, nos
research report
COVID-19

---
https://has-sante.fr/jcms/p_3520845/fr/detection-des-genomes-du-virus-de-la-grippe-a-et-b-et-du-sars-cov-2-par-rt-pcr-dans-un-contexte-d-exposition-a-risque-a-un-virus-influenza-zoonotique
2024
false
false
false
France
health technology assessment
influenza, nos
SARS-CoV-2
herpesvirus 1, cercopithecine
Biological Detection Test
Exposure
exposure to
reverse transcriptase polymerase chain reaction
genome
SARS Coronavirus
influenza
genome, nos
influenzavirus a
detective
influenza A virus
simian herpesvirus
genome, viral
influenza, human
Influenza B Virus
Application Context
Reverse Transcriptase-Polymerase Chain Reaction
Exhibition
Genome
genomics
Detection
risk
viruses
Influenza A Virus

---
https://www.cochrane.org/fr/CD015112/OCCHEALTH_quels-sont-les-benefices-et-les-risques-des-interventions-sur-le-lieu-de-travail-visant-reduire-le
2024
United Kingdom
review of literature
french abstract
SARS Coronavirus
health
Worksite
hazardous substances
Sector
Adverse Event Associated with Infection
workplace
risks and benefits
potential for infection
What Month is it
risk assessment
risk
Infection
SARS-CoV-2
occupation, nos

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2024-50/numero-6-juin-2024/depistage-sras-cov-2-infection-taux-vaccination-travailleurs-essentiels-non-soignants.html
2024
Canada
journal article
ATRX Mutation Analysis Was Not Performed
vaccination
First Degree Family History of Primary Brain Tumor Negative
Tumor Progression Absent After Initial Treatment
Has No Sibling
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant I-131 Therapy Negative
No History of Non-Cardiac Surgery
Adjuvant Post-operative Immunological Therapy Was Not Administered
Additional Molecular Studies Were Not Performed
Chemotherapy Not Received
Infection
ROS1 Rearrangement Analysis Was Not Performed
Genetic Screening
Intercurrent Illness is Absent at Onset of Chief Complaint
Severe Acute Respiratory Syndrome
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Norway
No History of Gestational Complication
Preoperative IV Antiemetics were not Administered
Other Preoperative IV Medications were not Administered
No Response to Intervention for Kawasaki Disease
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
mass screening
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Nitric Oxide Measurement
History of Medical Treatment Absent
EGFR Amplification Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Any Metastatic Diagnosis Absent
Characteristic
Preoperative IV Antacids were not Administered
Minor Criteria for Rheumatic Heart Disease Not Present
Lymph Node Dissection Was Not Performed
PTEN Mutation Analysis Was Not Performed
preventive immunization/medication
Fluorescence In Situ Hybridization Was Not Performed
Preoperative IV Opiates were not Administered
Neither Case or Control Status
ERBB2 Mutation Analysis Was Not Performed
SARS Coronavirus
Routine Cytogenetics Were not Completed
SDH Complex Mutation Analysis Was Not Performed
Severe acute respiratory syndrome-related coronavirus
screening
First Degree Family History Cancer Negative
Trial Screening
Caffeine Not Routinely Consumed
Radiation History Negative
Evidence of Disease Absent after Completion of Therapy
ATRX Gene Mutation Negative
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
TP53 Mutation Analysis Was Not Performed
vaccination
No History of Congenital Heart Disease
Additional Immunohistochemistry Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Screening Study
Chief Complaint Not Caused by Trauma
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Radiation Therapy Not Received
Site Screening
Documentation Absent
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
MGMT Promoter Methylation Testing Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
1p/19q Deletion Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Preoperative IV Sedation was Not Administered
Chief Complaint was Not Witnessed
Substance Screening
NF1 Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Unemployed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Regional Anesthesia was not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
New Disease is not Multifocal
MET Mutation Analysis Was Not Performed
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Paraneoplastic Syndrome is Not Present
RET Rearrangement Analysis Was Not Performed
No Known History of Alcohol Use
EGFR Gene Amplification Negative
Local Anesthesia Agents were not Administered
IDH Family Wildtype
Family History of Stomach Cancer Absent
IDH Family Mutation Analysis Was Not Performed
infectious disease, nos
Another Form of Birth Control was not Used
Cancer History Absent
History of Colorectal Cancer Negative
EGFR Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
No History of Rheumatic Fever
No History of Myopathy
Vaccination
10q23/PTEN Locus Deletion Analysis Was Not Performed
Last Screening
Use of Smokeless Tobacco at Time of Diagnosis Negative
Adverse Event Associated with Infection
Neither
No History of Neonatal Complication
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
caregivers
Eligibility Determination
New Tumor Event After Initial Treatment Absent
Not Lost to Follow-Up
PTEN Gene Mutation Negative
has provider
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
vaccination, nos
Physician Diagnosed Diabetes Absent
NON Mouse
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
NRAS Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
No Known History of Illicit Drug Use
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ALK Rearrangement Analysis Was Not Performed
IV Anesthesia was not Administered
Cancer Screening
Medication Not Taken
Patient was not Postmenopausal with no Prior Oophorectomy
Nitric Oxide
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
KIT Mutation Analysis Was Not Performed
Chemical/Occupational Exposure Absent
Tumor Reoccurrence Absent After Initial Treatment
Negation
No History of Kawasaki Disease
Hypertension Absent

---
https://dumas.ccsd.cnrs.fr/dumas-04342814
2023
France
dissertations, academic
Infection
SARS Coronavirus
elderly person, nos
CHFR Gene
pandemics
aged
Reasoning
france
Serious
Profile
Adverse Event Associated with Infection
Pandemic Disorder
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
Elderly
french
Resuscitation
Impact
SARS-CoV-2
severe
resuscitation
aged, 80 and over
infectious disease, nos

---
https://dumas.ccsd.cnrs.fr/dumas-04386119
2023
France
dissertations, academic
vaccination, nos
vaccination
preventive immunization/medication
vaccine, nos
SARS Coronavirus
vaccinia, nos
SARS-CoV-2
Vaccine
vaccines

---
https://www.sfm-microbiologie.org/2023/12/22/recommandations-indications-utilisation-tests-quadriplex-multiplex/
2023
France
public health guidelines
indication of
Respiratory System Finding
Rous Sarcoma Virus
Application Context
Multiplex Assay
nursing
SARS-CoV-2
Human Respiratory Syncytial Virus
hospitals
Respiratory System
SARS Coronavirus
Diagnosis Code
influenza A virus
Diagnosis Study
viruses
influenzavirus, nos
no diagnosis
Influenza C Virus
Use
Healthcare Facility
Date of Diagnosis
diagnosis
site of care, nos
Disease or Disorder
virus diseases
avian sarcoma viruses
hospital, nos
Off-Label use
suggestive of
respiratory syncytial viruses

---
https://www.srlf.org/article/lymphocyte-t-sars-cov-2-macrophage-alveolaire-bon-brute-truand-poumons
2023
France
critical appraisal or critical reading
macrophages, alveolar
lung
Murine Alveolar Macrophage
Bisphosphonate-Associated Osteonecrosis
Mouse Alveolus
t lymphocyte
T-Lymphocyte
Alveolar Macrophage
SARS Coronavirus
SARS-CoV-2
t-lymphocytes
alveolar macrophage
What Month is it
Well

---
https://minerva-ebp.be/FR/Article/2342
2023
Belgium
critical appraisal or critical reading
What Month is it
Reinfection
Privacy
SARS-CoV-2
Adverse Event Associated with Infection
infectious disease, nos
SARS Coronavirus
Reinfection
COVID-19 reinfection

---